CINECA IRIS Institutional Research Information System

CALDERONE, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.371
AS - Asia 12.480
EU - Europa 9.806
SA - Sud America 1.772
Continente sconosciuto - Info sul continente non disponibili 981
AF - Africa 499
OC - Oceania 34
Totale 51.943
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.616
SG - Singapore 4.036
IT - Italia 3.706
CN - Cina 3.432
HK - Hong Kong 1.869
BR - Brasile 1.462
SE - Svezia 1.375
VN - Vietnam 1.192
DE - Germania 1.038
BG - Bulgaria 716
FR - Francia 550
CA - Canada 548
GB - Regno Unito 511
FI - Finlandia 464
TR - Turchia 454
RU - Federazione Russa 362
KR - Corea 299
IN - India 277
UA - Ucraina 256
JP - Giappone 240
AT - Austria 202
CI - Costa d'Avorio 186
PL - Polonia 131
BD - Bangladesh 117
CH - Svizzera 115
NL - Olanda 99
IQ - Iraq 94
MX - Messico 91
AR - Argentina 89
ZA - Sudafrica 66
SN - Senegal 58
PK - Pakistan 53
SA - Arabia Saudita 53
ID - Indonesia 49
CO - Colombia 48
BE - Belgio 47
UZ - Uzbekistan 45
EC - Ecuador 44
ES - Italia 43
VE - Venezuela 37
KE - Kenya 32
MA - Marocco 31
AU - Australia 27
PE - Perù 27
NG - Nigeria 26
IL - Israele 25
JM - Giamaica 25
GR - Grecia 24
CL - Cile 23
PH - Filippine 23
TN - Tunisia 23
MY - Malesia 22
JO - Giordania 20
EG - Egitto 19
AZ - Azerbaigian 18
HU - Ungheria 18
IE - Irlanda 18
AE - Emirati Arabi Uniti 16
KZ - Kazakistan 16
NP - Nepal 16
PS - Palestinian Territory 16
PY - Paraguay 16
CZ - Repubblica Ceca 15
DK - Danimarca 15
IR - Iran 15
DZ - Algeria 14
LT - Lituania 14
BO - Bolivia 13
CR - Costa Rica 13
HN - Honduras 13
OM - Oman 13
UY - Uruguay 13
KG - Kirghizistan 12
NI - Nicaragua 12
AL - Albania 11
LB - Libano 10
DO - Repubblica Dominicana 9
PT - Portogallo 9
SK - Slovacchia (Repubblica Slovacca) 9
TW - Taiwan 9
ET - Etiopia 8
HR - Croazia 8
MD - Moldavia 8
RO - Romania 8
BJ - Benin 7
GT - Guatemala 7
PR - Porto Rico 7
BY - Bielorussia 6
MK - Macedonia 6
NZ - Nuova Zelanda 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
BB - Barbados 5
EE - Estonia 5
EU - Europa 5
KH - Cambogia 5
RS - Serbia 5
SV - El Salvador 5
AM - Armenia 4
AO - Angola 4
Totale 50.891
Salva come PNG Salva come JPEG
Città #
Ashburn 2.431
Singapore 2.297
Woodbridge 2.132
Hong Kong 1.839
Ann Arbor 1.651
Fairfield 1.557
San Jose 1.405
Houston 1.388
Chandler 1.240
Santa Clara 1.222
Dallas 1.045
Milan 767
Serra 728
Sofia 715
Shanghai 690
Beijing 668
Seattle 652
Wilmington 576
Cambridge 532
New York 532
Boardman 436
Los Angeles 392
Ottawa 392
Council Bluffs 385
Hefei 377
Princeton 313
Jacksonville 307
Lawrence 285
Seoul 273
Ho Chi Minh City 270
Izmir 267
Lauterbourg 252
Medford 236
Tokyo 226
Chicago 219
Nanjing 204
Hanoi 203
Helsinki 187
Abidjan 186
Dong Ket 186
Vienna 181
Frankfurt am Main 180
Des Moines 170
Pisa 164
Munich 157
Buffalo 150
Rome 146
London 143
Florence 130
Istanbul 120
São Paulo 114
Redondo Beach 111
Dearborn 107
Warsaw 107
San Diego 95
Atlanta 93
Orem 91
Nanchang 84
Boulder 77
Columbus 72
The Dalles 72
Redwood City 67
Bern 62
Dakar 58
Marseille 55
Lucca 53
Washington 53
Ogden 52
Jüchen 50
Da Nang 49
Livorno 49
Zurich 49
Shenyang 45
Turku 45
Brussels 44
Naples 44
Salt Lake City 44
Changsha 43
Kunming 43
Rio de Janeiro 43
Phoenix 42
Tianjin 42
Brooklyn 41
Grafing 41
Belo Horizonte 39
Baltimore 38
Nuremberg 38
Pune 38
Hebei 37
San Francisco 37
Tashkent 37
Chennai 36
Fuzhou 36
Montreal 36
Toronto 35
Guangzhou 34
Paris 34
Amsterdam 33
Falls Church 33
Norwalk 33
Totale 33.915
Salva come PNG Salva come JPEG
Nome #
Anti-Inflammatory and Vasorelaxant Effects Induced by an Aqueous Aged Black Garlic Extract Supplemented with Vitamins D, C, and B12 on Cardiovascular System 655
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 398
Resveratrol-like Compounds as SIRT1 Activators 391
Metformin conjugates and therapeutic use thereof 390
First examples of H2S-releasing glycoconjugates: stereoselective synthesis and anticancer activities 384
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 358
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 308
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme 304
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 299
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 295
The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage 290
Anti-Inflammatory and Antioxidant Effects Induced by Allium sativum L. Extracts on an Ex Vivo Experimental Model of Ulcerative Colitis 285
R(+)-METHANANDAMIDE INHIBITS EFS-INDUCED CHOLINERGIC RESPONSE IN GUINEA-PIG TRACHEA THROUGH A VR-MEDIATED MECHANISM 284
Beneficial Effects of Eruca sativa Defatted Seed Meal on Visceral Pain and Intestinal Damage Resulting from Colitis in Rats 277
Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease 272
R+-METHANANDAMIDE INHIBITS TRACHEAL RESPONSE TO ENDOGENOUSLY RELEASED ACETYLCHOLINE VIA CAPSAZEPINE-SENSITIVE RECEPTORS 268
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 260
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 252
Antioxidant and Antisenescence Effects of Bergamot Juice 247
Antioxidant, cardiomyocyte anti-ageing properties and phytochemical profile of Citrus bergamia juices 247
The citrus flavanone naringenin produces cardioprotective effects in hearts from 1 year old rat, through activation of mitoBK channels 243
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 240
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 236
Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications 236
Design, synthesis and biological evaluation of new H2S-releasing rivastigmine derivatives as neuroprotective molecules 230
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 229
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 229
Memantine prodrug as a new agent for alzheimer’s disease 227
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 225
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 225
Emerging role of the cardiac lipidome in the progression of heart failure. 224
Glucoerucin, Glucosinolate From Brassicaceae Vegetables, Improves the Metabolic Profile in a Murine Model of Diet-Induced Obesity 223
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 221
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 221
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 218
1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors 218
Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives 217
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 217
A NEW NITRIC OXIDE RELEASING ANTI-DIABETIC HYBRID DRUG: FROM THE DESIGN TO THE PHARMACOLOGICAL CHARACTERIZATION 216
D -Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase 213
In-vitro evaluation of new pharmacodynamic hybrids with insulin secretagogue and NO-donor activity 209
An update on hybrid drugs in cardiovascular drug research 208
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 208
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates 207
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 205
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 205
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 200
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 199
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 198
SYNTHESIS AND BETA-BLOCKING ACTIVITY OF (R,S)-(E)-OXIMEETHERS OF 2,3-DIHYDRO-1,8-NAPHTHYRIDINE AND 2,3-DIHYDROTHIOPYRANO[2,3-B]PYRIDINE: IDENTIFICATION OF BETA 3-ANTAGONISTS 197
An alternative method to evaluate the nature of an antagonist and its potency. A theoretical approach 194
AN IN VIVO EXPERIMENTAL METHOD TO PREDICT THE TORSADOGENIC POTENTIALITY OF DRUGS: EVALUATION OF QT PROLONGATION IN ANAESTHETISED GUINEA-PIG 194
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 194
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 194
Synthesis of 1,8-naphthyridine derivatives: potential antihypertensive agents. Part VIII 193
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 189
TORSADOGENIC CARDIOTOXICITY OF ANTIPSYCHOTIC DRUGS: A STRUCTURAL FEATURE, POTENTIALLY INVOLVED IN THE INTERACTION WITH CARDIAC HERG POTASSIUM CHANNELS 187
Synthesis of 1,8 - naphthyridine derivatives: potential antihypertensive agents. Part VII 187
A simplified empirical approach to evaluate the dissociation constant of a full agonist by the irreversible receptor inactivation method 186
Pharmacological study on the cardiovascular activity of no-sartans, pharmacodynamic hybridsexhibiting at1-antagonist and no-donor properties 186
QSAR models for predicting biological properties, developed by combining structure- and ligand-based approaches: an application to the hERG potassium channel inhibition 186
New amido derivatives as potential BKCa potassium channel activators. XI 186
Spirocyclic Benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel 186
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 185
Voltage-operated potassium (Kv) channels contribute to endothelium-dependent vasorelaxation of carvacrol on rat aorta 183
Valore nutraceutico dei flavonoidi presenti nel genere Citrus. Evidenze epidemiologiche, cliniche e pre-cliniche degli effetti protettivi dei Citrus flavanoni sulle funzioni cardiovascolari 182
ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL ATP-SENSITIVE POTASSIUM CHANNELS 180
A modified aortic multiple-ring preparation for functional studies 180
The nutraceutical value of olive oil and its bioactive constituents on the cardiovascular system. Focusing on main strategies to slow down its quality decay during production and storage 180
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 180
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 179
New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties 179
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro 178
NO-Sartans: A New Class of Pharmacodynamic Hybrids as Cardiovascular Drugs 176
Differential Effects of Fondaparinux and Bemiparin on Angiogenic and Vasculogenesis-like processes. 175
Large conductance Ca2+-activated K+ channel (BKCa) activating properties of a series of novel N-arylbenzamides: Channel subunit dependent effects 175
Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs 175
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 175
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 175
Conformationally restrained analogues of sympathomimetic catecholamines: Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1(2H)-2′,5′- morpholines] 174
Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel 174
VASODILATOR ACTIVITY OF MICHELIA FIGO SPRENG (MAGNOLIACEAE) BY IN VITRO FUNCTIONAL STUDY 173
QT PROLONGATION IN GUINEA PIGS FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG-CANDIDATES. II 173
(+/-)-NARINGENIN AS LARGE CONDUCTANCE Ca2+-ACTIVATED K+ (BKCa) CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 173
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 173
Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels 173
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis 172
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 171
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 171
H2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma 171
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODELS FOR PREDICTING BIOLOGICAL PROPERTIES, DEVELOPED BY COMBINING STRUCTURE- AND LIGAND-BASED APPROACHES: AN APPLICATION TO THE HUMAN ETHER-A-GO-GO-RELATED GENE POTASSIUM CHANNEL INHIBITION 170
New spiromorpholone- and spiromorpholine-benzopyrane derivatives as potential activators of mito-KATP channel 169
Antiviral properties of an aqueous extract of a green algae Caulerpa taxifolia (Vahl) C. Agardh. 168
Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X 168
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: 1,5-DIARYLPYRROLE NITROOXYALKYL ETHERS AND RELATED COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITING NITRIC OXIDE DONORS 167
5-(4'-SUBSTITUTED-2'-NITROANILINO)-1,2,3-TRIAZOLES AS NEW POTENTIAL POTASSIUM CHANNEL ACTIVATORS. I 166
Cardiac ATP-sensitive potassium channels, a potential target for an anti-ischaemic pharmacological strategy 166
Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands 165
1-(1,2,3-TRIAZOL-4-YL)-BENZIMIDAZOLONES, A NEW SERIES OF HETEROCYCLIC DERIVATIVES 164
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 163
Totale 21.891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.224 0 220 98 159 537 536 107 172 130 108 252 905
2022/20234.210 523 540 277 346 465 574 41 272 808 24 212 128
2023/20243.299 333 405 373 189 467 624 146 95 59 88 125 395
2024/202510.350 95 410 126 559 850 1.123 809 581 1.006 1.344 1.284 2.163
2025/202613.026 703 1.485 1.322 1.076 1.268 1.198 2.117 656 935 1.303 448 515
2026/20272.871 992 1.879 0 0 0 0 0 0 0 0 0 0
Totale 51.943